Market Overview

Why Trevena's Stock Is Trading Higher Today

Why Trevena's Stock Is Trading Higher Today

Trevena (NASDAQ: TRVN) shares are trading higher on Friday after Cantor Fitzgerald initiated coverage on the company's stock with an Overweight rating and announced a $5 price target.

Trevena is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.

Trevena's stock traded up 15.46% at $1.81 per share at the time of publication on Friday. The stock has a 52-week high of $3.68 and a 52-week low of 46 cents.

Latest Ratings for TRVN

Sep 2020GuggenheimInitiates Coverage OnBuy
Aug 2020Cantor FitzgeraldInitiates Coverage OnOverweight
Aug 2020HC Wainwright & Co.MaintainsBuy

View More Analyst Ratings for TRVN
View the Latest Analyst Ratings


Related Articles (TRVN)

View Comments and Join the Discussion!

Posted-In: why it's movingPenny Stocks Price Target Initiation Analyst Ratings

Latest Ratings

INTCJP MorganMaintains70.0
STMCanaccord GenuityMaintains47.0
ELDeutsche BankMaintains248.0
UAADeutsche BankMaintains13.0
INTCDeutsche BankMaintains55.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at